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Cutaneous cryptococcosis usually develops secondary to hematogenous spread in immunocompromised
hosts. Primary cutaneous cryptococcosis (PCC) is a rare condition characterized by localized skin erup-
tions and positive culture for Cryptococcus neoformans but without dissemination to the internal organs.
Herein, we describe a typical case of PCC in an immunocompetent male who presented with a 1-month
history of scattered erythematous indurated papules and plaques on his arm and without fever. The
histology of his skin, tissue culture, and multiplex polymerase chain reaction (PCR) conﬁrmed cutaneous
cryptococcal infection by C neoformans var. neoformans. After extensive work-ups showed no evidence of
systemic dissemination or underlying cellular-immunity deﬁciency, the diagnosis of primary cutaneous
cryptococcosis was made. Treatment with ﬂuconazole 400 mg daily for 14 days followed by 200 mg daily
for another 14 days led to complete resolution of the skin lesions, and subsequent follow-up showed no
signs of relapse.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Cryptococcus neoformans is an opportunistic encapsulated yeast
that infects immunocompromised human hosts.1 Four serotypes
have been identiﬁed: C neoformans var. grubii (serotype A); C neo-
formans var. gattii (serotypes B and C); and C neoformans var. neo-
formans (serotype D).2,3 Serotype D is most common in cutaneous
cryptococcosis.4,5 However, recent further subspeciation of Cryp-
tococcus has concluded that other serotypes can also cause cuta-
neous cryptococcal infections.6,7 Cutaneous cryptococcosis is
extremely rare in immunocompetent hosts. In immunocompro-
mised hosts, it usually disseminates from a distant site and is
characterized by a poor outcome.8 Primary cutaneous cryptococ-
cosis (PCC) is a rare entity with a favorable prognosis.9 This case
report describes an immunocompetent and otherwise healthy
nonfebrile elderly male with scattered erythematous indurated
papules and plaques on the arm. PCC was caused by C neoformans
var. neoformans as evidenced by skin culture and multiplex poly-
merase chain reaction (PCR). There were no signs of systemic
dissemination and the lesions completely resolved after 4 weeks of
ﬂuconazole treatment.tology, Kaohsiung Veterans
hsiung City 81362, Taiwan.
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An87-year-old retiredmale living in a rural area presentedwith a 1-
month history of scattered asymptomatic erythematous indurated
papules and plaques on the right arm (Figure 1). The patient was
otherwise healthy and showed no lymphadenopathy, fever, night
sweating, malaise, weight loss, headaches, or other constitutional
symptoms. Before the eruption, he had no history of contact with
pigeons and no trauma or other medical conditions requiring long-
termmedication other than intermittent pruritus due to eczema. He
occasionally used topical corticosteroid agents during ﬂare-up of
eczema. A skin biopsy was performed under the impression of
atypical infection or cutaneous lymphoma. Skin histology showed
dermal granulomatous inﬁltrates composed of histiocytes, multi-
nucleated giant cells, and necrosis (Figure 2A). Numerous variable-
sized yeasts surrounded by clear halos and sporadic narrow-based
budding were identiﬁed by periodic acid-Schiff stain (Figure 2B)
and mucicarmine stain (Figure 2C). A tissue culture showed growth
of Cryptococcus species, which was conﬁrmed by a multiplex PCR
preferable to C neoformans var. neoformans (Figure 3) (primers 5’-
GGAACAGCAACCACACTACTG; 5’-CATATTGGGTGGCATCTTACTGAGG
GA; 5’-CCAGGGAACATGTTGTTGAC; 5’-GTTGTGGAAGGCAAAGAAAC,
based on the report of Ito-Kuwa et al10).Both human immunodeﬁ-
ciency virus serology and serum cryptococcal antigen test were
negative. A lumbar puncturewas not performedbecause the patient
showed no symptoms or signs of meningeal involvement.n. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Scattered erythematous indurated papules and plaques on the right arm.
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plasma cortisol, and adrenocorticotropic hormone level, T-cell
subset analysis, lymphocytemitogenstimulation test, serumprotein
electrophoresis, chest radiograph, and cranial computed tomog-
raphy were normal. Blood, urine, and sputum cultures showed
negative results. Based on the clinical and laboratory results indi-
cating an immunocompetent status without dissemination, the
diagnosis of PCC was made. After intravenous administration of
400mgﬂuconazole daily for 7 days, the patientwas dischargedwith
a prescription for oral ﬂuconazole 400 mg daily for another 7 days
followed by 200 mg daily for 14 days. The 1-month treatment
completely resolved the skin lesions (Figure 4), and the lesions
showed no recurrence after 2 months of follow-up.Figure 2 (A) Results of histopathologic examination depicting dermal granulomatous
inﬁltrate (40) (hematoxylin and eosin stain). (B) Periodic acid-Schiff stain in high
power view (400) showing numerous spherical encapsulated yeasts. (C) Muci-
carmine staining results (400).Discussion
Cryptococcosis is an opportunistic infection caused by encapsu-
lated yeast, C neoformans. This pathogen is found in soil, fruit,
vegetables, decaying wood, and the feces of many birds, especially
pigeons.9 It usually emerges in immunocompromised patients,
such as those with a history of underlying malignancy, organ
transplant, acquired immunodeﬁciency syndrome, or corticoste-
roid therapy,4,11,12 although occasionally it may occur in immuno-
competent hosts.13
Cutaneous cryptococcosis usually results from hematogenous
dissemination from other distant organs in immunocompromised
hosts, referred to as secondary cutaneous cryptococcosis (SCC).14
The airway is believed be the main entry portal. Cutaneous
involvement occurs in 10-20% of cases of disseminated cryptococ-
cosis.2,8,15 However, direct inoculation is a possible route, which
causes primary cutaneous cryptococcosis (PCC).11 A history of
trauma is themost frequently reported risk factor to provide a portal
of entry, and foreign body puncture and animal-related trauma are
the most common related causes. Patients with hobbies or occupa-
tions that put them at risk of injuries with exposure to soil, dust,
wood sticks or debris, or bird droppings are at the greatest risk of
PCC.16 The mean duration between inoculation and clinical mani-
festation is usually 8 days. In addition, C neoformans var. neoformans
has a lower thermotolerance compared with the other serotypes,
which may explain its dermatotrophism.15,16
The diverse clinical manifestations of PCC include papules,
pustules, nodules, plaques, vesicles, ulcers, ecchymosis, cellulitis,
subcutaneous lesions resembling erythema nodosum, herpetiform
or molluscum contagiosum-like lesions, and polymorphic
lesions.5,8,12 Therefore, cutaneous cryptococcosis should besuspected if the skin eruptions respond poorly to standard treat-
ment, and a diagnostic skin biopsy should be performed.15
The rare cases of PCC usually have favorable outcomes, even in
immunocompromised patients.4,8 Compared with patients with
SCC, patients with PCC tend to be older and are characterized by
Figure 3 Molecular characterization of Cryptococcus spp. Identiﬁcation of this frag-
ment preferably corresponding to C neoformans var. neoformans.10 Products from
primer Lac1 showed a single broad band at around 1 kilo base pairs. Products from
primer Cap64 showed a band at around 400þ base pairs. Products from all primers
showed the combinational bands from both sets of primers. The lack of additional
several bands at around 200þ or 400þ base pairs in our polymerase chain reaction
product may be used to distinguish the var. neoformans and serotypes A/B/C. There
may be two bands comprising the broad band of 800e1000 base pairs seen in our
result. The existence of a band at around 400þ base pairs under Cap64 conﬁrms the
species of Cryptococcus. Thus, the infection of the skin tissue caused by C neoformans
var. neoformans (serotype D) is preferable.
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PCC tend to reside in rural areas whereas those with SCC tend to
reside in urban areas. The two diseases have a similar male-to-
female ratio (approximately 1:1).1,2,8 Indicators of PCC include an
absence of dissemination, solitary skin lesions on unclothed areas,
history of skin injury, participation in outdoor activities or exposure
to bird droppings, and isolation of C neoformans serotype D.1,8,15,17
However, Xiujiao and Ai’e18 observed that the presence of C neo-
formans serotype Dmay not be an essential criterion for a diagnosis
of PCC because both C gattii and C neoformans var. neoformans canFigure 4 Complete recovery with minor eczematous scaling after 1 month of
treatment.also lead to infection in immunocompetent hosts.2,17 In immuno-
competent hosts, the most common sites of lesions are the facial
area and upper extremities. Immunocompromised hosts are char-
acterized by multiple lesions, typically in the trunk or lower
extremities.16,19
A diagnosis of PCC should be considered a diagnosis of exclu-
sion, because cutaneous lesions are a symptom of systemic cryp-
tococcosis.2,19,20 Extensive work-ups including a detailed history,
physical examination, and laboratory examination are essential to
exclude dissemination. A lumbar puncture is indicated when
symptoms of central nervous system (CNS) involvement are
present; however, its usefulness is debatable in the absence of
localizing signs.9,19 Underlying immunodeﬁciency should also be
evaluated.4,9,16
Because the optimal treatment regimen for cutaneous crypto-
coccosis is not well established, treatment usually varies according
to the extent of disease and host immunocompetence.16,21,22 In
immunocompetent patients, the Infectious Disease Society of
America guidelines recommend treating cryptococcal CNS infection
or dissemination with amphotericin B (0.7-1 mg/kg/day) plus ﬂu-
cytosine (100 mg/kg/day) for at least 4 weeks, followed by
consolidation therapy with ﬂuconazole (400-800 mg/day) for
a minimum of 8 weeks and maintenance therapy with ﬂuconazole
(200 mg/day) for 6-12 months.11,21,22 As for pulmonary disease,
ﬂuconazole 400 mg daily for 6-12 months is recommended in mild
to moderate disease. The regimen differs in severe or progressive
disease, which is the same as treating CNS involvement.11,21,22
Secondary cutaneous cryptococcosis is treated in a manner
similar to that of CNS infection, whereas ﬂuconazole 400 mg daily
for 6-12 months is recommended to treat PCC in an immunocom-
petent host.11, 21, 22 However, a short-term (2 weeks) course of
ﬂuconazole treatment (200 mg daily) has also proven to be effec-
tive in PCC.16
The clinical manifestations in the current study included a cir-
cumscribed skin lesion in an unclothed area without evidence of
dissemination or cellular immunity deﬁciency. A tissue culture of C
neoformans var. neoformans and a good response after 1 month of
treatmentwere consistentwith a diagnosis of PCC. Althoughno clear
source of infectionwas identiﬁed, chronic scratching was a plausible
portal of entry. Even in immunocompetent patients, a chronic course
of indolent but unprotected scratching wounds should always raise
the suspicion of atypical infections, including PCC.References
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